Alpha Genomix Laboratories Inc V Shane Crandall

Key Facts

Transaction Type

Issues

• Whether El Shawa and Crandall breached their fiduciary duties owed to Alpha shareholders by executing the Employment Agreement in bad faith and self-dealing. The defendants argued that El Shawa orchestrated a scheme to keep his position as CEO by including change-in-control provisions, and that neither party acted in good faith. The court had to assess whether the evidence demonstrated bad faith or gross deviation from the standard of care.
• Whether Crandall was barred from bringing suit under an indemnification provision contained in the Share Exchange Agreement, and whether the Change-in-Control Provision of the Employment Agreement violated the federal Eliminating Kickbacks in Recovery Act (EKRA), 18 USC § 220. The trial court did not rule on these issues, so they were remanded for consideration.
• Whether the Employment Agreement between Crandall and Alpha had valid consideration, specifically if the promise to pay severance in the event of a change in control was supported by consideration given that Crandall was already receiving increased salary and commissions before the agreement was finalized. The court needed to determine if Crandall's continued employment in his new position constituted sufficient quid pro quo consideration for the severance provision.
• Whether ConGen assumed liability for breach of Crandall's Employment Agreement when it acquired all of Alpha's shares through a share exchange. The court needed to determine if the transaction constituted a de facto merger or continuation doctrine application, and whether ConGen assumed Alpha's contractual obligations.
• Whether a change in control occurred under the Change-in-Control Provision of the Employment Agreement, specifically whether Sasnett's role changed after ConGen's acquisition of Alpha's shares triggered the severance provision. The provision defined change in control as occurring upon a change in the CEO and/or Executive Vice President of Sales of Alpha.

Holdings

• The Court of Appeals of Georgia affirms the trial court's judgment in all other respects regarding Crandall's breach of contract claims against Alpha Genomix Laboratories, Inc. and Consultative Genomics, LLC, while vacating the judgment in part and remanding for the trial court to determine whether ConGen assumed liability for breach of the employment contract when it acquired Alpha's shares.
• The appellate court vacates the judgment in part and remands for the trial court to consider under the proper legal framework whether ConGen assumed liability for breach of the employment contract when it acquired all of Alpha's shares through the Share Exchange Agreement, noting that generally when a company acquires all shares of another company, the purchasing company does not assume the liabilities of the selling company unless there is an agreement to assume liabilities, the transaction is a merger, it is a fraudulent attempt to avoid liabilities, or the purchaser is a mere continuation of the predecessor corporation.
• On remand, the trial court should address two other issues that were raised below but were not ruled on by the court in its judgment: whether Crandall's claims are barred by the contractual indemnification provision contained in the Share Exchange Agreement or by the federal Eliminating Kickbacks in Recovery Act (EKRA), 18 USC § 220, which the defendants argue makes the Change-in-Control Provision of the Employment Agreement unenforceable.

Remedies

Monetary Damages

Legal Principles

• The court applied the presumption of good faith applicable to fiduciary duty contexts. The evidence, when construed in favor of the judgment, supported a finding that El Shawa acted in good faith and for legitimate business reasons in negotiating and executing the Employment Agreement. The trial court was entitled to find that the process followed was done in good faith and with ordinary care. The court noted that there was conflicting testimony on these matters, but resolution of conflicts was for the trial court, not the appellate court.
• The court held that there was no evidence that El Shawa or Crandall breached their fiduciary duties owed to Alpha shareholders when executing the Employment Agreement. El Shawa acted within his authority as CEO under the Georgia Business Corporation Code, and the decision to enter into the agreement did not require shareholder approval. The negotiations were arms-length and the agreement benefitted Alpha. The trial court was entitled to find that El Shawa had authority to negotiate and execute the Employment Agreement on behalf of Alpha and therefore to bind the company to that Agreement.
• The court found that Crandall's continued employment in his new National Sales Director position constituted valid consideration for the Employment Agreement. The evidence showed that Crandall began serving in the new position while the agreement terms were being finalized, and his continued employment was contingent on reaching agreement on compensation and severance benefits. This quid pro quo was sufficient to establish consideration for the Agreement, including the Change-in-Control Provision. The trial court was authorized to find the Employment Agreement was supported by consideration.

Precedent Name

• Lambeth v. Three Lakes Corp.
• Brown Transp. Corp. v. Street
• Tattersall Club Corp. v. White
• Edwards v. Grapefields, Inc.
• Royal Crown Cos. v. McMahon
• Coleman v. DaimlerChrysler Svcs. of North America
• Mon Ami Intl. v. Gale

Key Disputed Contract Clauses

• Section 7.5(a) of the Employment Agreement provides severance benefits upon termination following a Change in Control, including: (i) Base Salary for 12 months following Termination Date, (ii) Commission payment equal to last full employment year, and (iii) Continued health, life, and disability insurance coverage for 12 months. The provision allows termination by Employee within 90 days after Change in Control or Company-initiated termination without Cause. The court found this provision was supported by valid consideration.
• The Share Exchange Agreement between Alpha and ConGen contained an indemnification provision that defendants argued barred Crandall from bringing suit. The provision allegedly required indemnification for claims related to the share exchange transaction. The trial court did not rule on this issue in its judgment, so the appellate court vacated the judgment in part and remanded for the trial court to address whether this indemnification provision bars Crandall's claims for breach of contract.
• Section 7.5 of the Employment Agreement defines a 'Change in Control' as occurring when there is a change in the CEO and/or Executive Vice President of Sales of the Company. This provision triggers severance benefits including 12 months of base salary, commission payment, and continued health/life/disability insurance coverage. The trial court found that Sasnett no longer served as Executive Vice President of Sales after ConGen's acquisition, satisfying the change-in-control definition, though defendants argued Alpha remained an active company with El Shawa as CEO and Sasnett still as Executive Vice President of Sales.

Cited Statute

• Georgia Business Corporation Code provision governing director fiduciary duties
• Georgia Business Corporation Code provision governing officer fiduciary duties
• Georgia statute governing attorney fees in civil cases
• Federal statute prohibiting kickbacks in substance abuse treatment recovery programs
• Georgia Business Corporation Code provision governing CEO authority to conduct ordinary business

Judge Name

• Watkins
• Barnes
• Land

Passage Text

• And while there was conflicting testimony regarding this matter, again, resolution of those conflicts was for the trial court, not this Court. Bowen Builders Group, 252 Ga. App. at 56. Accordingly, the trial court was authorized to find that there was a 'a change in the Executive Vice President of Sales of [Alpha]' under the Change-in-Control Provision of the Employment Agreement, such that Crandall was entitled to seek severance benefits upon the termination of his employment.
• Viewed in that light, the evidence showed that Crandall was promoted and began serving in his new National Sales Director position at Alpha when the terms of his new written employment agreement were still in the process of being finalized, and only after he received assurances from El Shawa and Sasnett that he would be provided a new agreement that included increased compensation and severance benefits. The evidence further showed that after starting his new position, Crandall repeatedly inquired about the status of his employment agreement until its terms were finalized and the contract was executed. These facts, construed in favor of Crandall, authorized the trial court to find that Crandall's continued employment in his new position was contingent on the parties reaching agreement on and finalizing a new employment agreement that included severance benefits. In other words, the trial court was authorized 'to find a quid pro quo' — that Crandall would remain in his new position at Alpha in return for an agreed-upon compensation and severance package.
• In determining whether ConGen assumed the liabilities of Alpha when it purchased all of Alpha's shares, the trial court did not analyze the question under the aforementioned framework. Moreover, while the trial court referred to the transaction as being both 'in the form of a share exchange agreement' and as creating a 'merged corporation,' the uncontroverted evidence showed that the transaction was a statutory share exchange under which ConGen acquired all of Alpha's shares rather than a statutory merger, and the trial court did not apply the 'de facto' merger test, as set out supra in footnote 11, in addressing the issue. Accordingly, we vacate the trial court's judgment in part and remand for the court to consider whether ConGen assumed the liabilities of Alpha, including liability for breach of the Employment Agreement, under the proper legal framework.

Damages / Relief Type